Helituspan

Helituspan is a pharmaceutical product that contains a dry extract of Hederae Folium (ivy leaf) standardized at a 5‑7.5:1 ratio and prepared with 30 % ethanol (m/m) as the extraction solvent. It is intended for oral administration and is marketed within the European Union. The product’s strength and dosage form are not specified in the available data, and it is listed without a defined prescription status.

Helituspan contains ivy leaf extract, which has been studied for its potential role in respiratory support. Clinical and traditional use suggest the following applications:

- Adjunctive support for occasional, non‑productive cough in adults. - Complementary use in mild upper‑respiratory tract irritation. - Inclusion in herbal formulations aimed at facilitating expectoration. - Supportive care for throat discomfort associated with dry cough. - Possible use as part of a multi‑herb product for bronchial soothing.

Reported adverse effects of ivy leaf extract vary in frequency and severity. The following categories summarize observations from clinical and post‑marketing sources.

Common: - Mild gastrointestinal discomfort such as nausea or abdominal cramps. - Transient skin rash or pruritus. - Mild headache. - Dizziness.

Serious: - Allergic anaphylactic reaction. - Severe bronchospasm in sensitive individuals. - Rare hepatic enzyme elevation.

When considering Helituspan, several precautionary measures should be observed to minimize risk.

- Do not use in individuals with known hypersensitivity to ivy or related plants. - Avoid use in children under 12 years unless advised by a healthcare professional. - Caution in patients with asthma or chronic obstructive pulmonary disease. - Pregnancy and lactation status is not established; consult a clinician. - Monitor for gastrointestinal upset during initial use. - Discontinue if signs of allergic reaction appear.

Ivy leaf extract may interact with certain medicines or substances. The interactions are grouped by the level of concern.

Avoid: - Concurrent use with potent bronchodilators may increase risk of bronchospasm. - Combination with other herbal expectorants containing similar active compounds may potentiate effects. - Use together with anticoagulant therapy is not recommended without monitoring.

Use with caution: - May enhance the effect of antihistamines, leading to increased sedation. - Potential additive gastrointestinal effects when taken with NSAIDs. - Concurrent use with other hepatically metabolized drugs should be monitored.